non small cell lung cancer icd 9 cm code

... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94 :153-156. 2. Non- small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: a meta-analysis ... advanced non- small- cell lung cancer: a phase III trial of the European Organiza- tion for Research and Treatment of Cancer Lung Cancer Group – EORTC 0 897 5. J Clin Oncol 2003, 21: 390 9- 391 7. 15. ... randomized clinical tri- als. BMJ 199 5, 311: 899 -90 9. 3. Bunn PA, Kelly K: New chemotherapeutic agents prolong sur- vival and improve quality of life in non- small cell lung cancer: a review of the literature...

Ngày tải lên: 18/06/2014, 15:20

... sensitivity overall 92 % delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83% IHC specificity overall 99 % delE746-A750 Ab 100% 92 % 100% 40% 98 .8% L858R Ab 100% 96 .6% 36% 98 .8% Simonetti ... Non- small- cell lung cancer harbouring mutations in the EGFR kinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ... Rosell R, Klughammer B: Clinical outcomes in non- small- cell lung cancer patients with EGFR mutations: pooled analysis. J Cell Mol Med 20 09, 14(1-2):51- 69. 7. Marchetti A, Martella C, Felicioni L,...

Ngày tải lên: 18/06/2014, 16:20

... after complete resection of non- small cell lung carcinoma. Cancer Res 2010, 70:8288 -98 . 19. Goldstraw P: The 7th Edition of TNM in Lung Cancer: what now? J Thorac Oncol 20 09, 4:671-3. 20. Sandler ... 48 190 59 High 158 47 84 58 Missing 15 5 SCC (n = 191 ) NS Low 89 47 133 64 0.88 High 98 51 120 68 Missing 4 2 SCC, N0 0.15 NS Low 59 47 160 79 High 68 53 1 29 67 SCC, N+ 0.034 Low 30 50 49 32 High ... 20 09, 14:253-63. 23. Donnem T, Al-Saad S, Al-Shibli K, et al: Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer...

Ngày tải lên: 18/06/2014, 16:20

... <0.0001 Progressive -0.1 798 0.021 69 99 -8. 29 <0.0001 Response 0.0 193 0.006556 99 2 .94 0.004 Stable 0 . . . . Neutropenia -0.0 897 3 0.01543 99 -5.82 <0.0001 Febrile Neutropenia -0. 090 02 0.01633 99 -5.51 <0.0001 Fatigue ... 0.018 49 99 -3 .97 0.0001 Nausea & vomiting -0.04802 0.01618 99 -2 .97 0.0038 Diarrhoea -0.0468 0.01553 99 -3.01 0.0033 Hair loss -0.04 495 0.01482 99 -3.03 0.0031 Rash -0.03248 0.01171 99 -2.77 ... Staging of small cell and non- small cell lung cancer. University of Iowa Virtual Hos- pital; 199 9. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat- ment in patients with lung cancer: ...

Ngày tải lên: 18/06/2014, 19:20

... re- sponse( 79) 0 ~99 Negative 100~ 199 40% 200~ 299 100 Positive 300~400 58% EGFR protein status is associ- ated with gefitinib treatment response (23) 0 ~99 Negative 100~ 199 39% 200~ 299 200 ... ZD18 39) in non- small- cell lung can- cer. Br J Cancer. 2004; 91 (2): 208-12. 89. Bailey R, Kris M, Wolf M. Gefitinib (Iressa, ZD 18 39) mono- therapy for pretreated advanced non- small cell lung cancer ... 18(6): 10 59- 68. 3. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 199 5; 75(1 Suppl): 191 -202. 4. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 199 9; 10 (Suppl...

Ngày tải lên: 08/08/2014, 17:20

... continue treatment. Introduction In non- small cell lung cancer (NSCLC), mediastinal lymphnode involvement comprises a wide spectrum of severity. In fact, while 9% of patients with IIIA-N2 NSCLC ... Carteni’ 1 Abstract Background: Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC), presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi 1* , Giuseppe Di Lorenzo 1 , Carlo Buonerba 1 , Guglielmo Monaco 2 ,...

Ngày tải lên: 09/08/2014, 03:21

... with mitomycin, vindesine, and cisplatin in unresectable stage III non- small- cell lung cancer. J Clin Oncol 199 9, 17:2 692 -2 699 . 3. Komaki R, Seiferheld W, Curran W, Langer C, Lee J, Hauser S, ... stage small cell lung cancer. Int J Radiat Oncol Biol Phys 199 9, 43: 39- 45. 31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lung cancer ... SD = 6.00 0.008 V35 9. 92% (3. 89- 18.65%) = 7.57, SD = 2.86 = 11 .95 , SD = 4.64 0.011 V40 8.20% (3. 29- 13.61%) = 5 .91 , SD = 2.48 = 9. 26, SD = 3.75 0.015 V45 7.42% (2.73-10 .99 %) = 4.41, SD = 2.25...

Ngày tải lên: 09/08/2014, 08:23

... of non- small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-3 89. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapy in treatment of stage I non- small cell ... histogram analysis for pneumonitis after 3D treatment for non- small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 199 9, 45:323-3 29. 25. Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley ... early- stage non- small- cell lung cancer: clinical implications. Radiother Oncol 2010, 94 :1-11. 27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic body radiotherapy for T1-3N0 non- small cell...

Ngày tải lên: 09/08/2014, 09:20

... Stereotactic Body Rad iotherapy, Oligometastases, Non- Small Cell Lung Cancer Background Non- small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States [1]. Patients ... Okunieff 2 and Michael T Milano 1* Abstract Background: Standard therapy for metastatic non small cell lung cancer (NSCLC) includes palliative systemic chemotherapy and/or radiotherapy. Recent studies ... Open Access Comparison of outcomes in patients with stage III versus limited stage IV non- small cell lung cancer Praveena Cheruvu 1 , Su K Metcalfe 1 , Justin Metcalfe 1 , Yuhchyau Chen 1 , Paul...

Ngày tải lên: 09/08/2014, 09:20

... radiotherapy for stage I non- small cell lung cancer. Radiother Oncol 2007, 85:4 29- 434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat- eral primary lung cancers: the Indiana university ... with operable lung cancer. A randomized phase III trial of Radiosurgery Or Surgery for operable Early stage (stage 1A) non- small cell Lung cancer (ROSEL, ClinicalTrials.gov ID = NCT0068 798 6) has been ... MA, Slotman BJ, Lagerwaard FJ: Critical review of nonsurgical treatment options for stage I non- small cell lung cancer. Oncologist 2008, 13:3 09- 3 19. 41. Brock J, Ashley S, Bedford J, Nioutsikou...

Ngày tải lên: 09/08/2014, 09:22

... distribution of occult micrometas- tases in lymph nodes of patients with non- small- cell lung car- cinoma. J Natl Cancer Inst 199 3, 85: 493 - 498 . 17. Herth FJ, Eberhardt R, Krasnik M, Ernst A: Endobronchial ... in Stage III non- small cell lung cancer? An analysis of recur- rences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002, 54(4) :99 9-1006. 10. ... a phase I/II dose esca- lation trial in non- small cell lung cancer using three-dimen- sional conformal radiotherapy. Radiother Oncol 2003, 66:1 19- 126. 9. Senan S, Burgers J, Samson MJ, can Klaceren...

Ngày tải lên: 09/08/2014, 09:22

... the planning CT images was 170 cm 3 (range 25 cm 3 - 353 cm 3 ); the GTV volume decreased to median 124 cm 3 ( 19 cm 3 - 325 cm 3 ) and 100 cm 3 (10 cm 3 - 270 cm 3 ) mid-way and at the end ... shrinkage was observed with median GTV volumes of 170 cm 3 (range 42 cm 3 - 353 cm 3 ), 124 cm 3 ( 19 cm 3 - 325 cm 3 ) and 100 cm 3 (10 cm 3 - 270 cm 3 ) at treatment planning, mid-way and at the ... glands [8]. Similar findings were made for non- small- cell lung cancer (NSCLC), where a continuous tumor regression during radiotherapy was observed [9] . This continuous tumor regression during...

Ngày tải lên: 09/08/2014, 10:20

... peripheral stage I non- small cell lung cancer. Lung Cancer 199 9, 26:137-142. 23. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation in early stage (T1-2N0) non- small cell lung cancer. Radiother Oncol ... http://www.ro-journal.com/content/1/1/30 Page 9 of 9 (page number not for citation purposes) inoperable non- small cell lung cancer without mediastinal involvement (clinical stage N0, N1). Strahlenther Onkol 199 6, 172:4 89- 495 . 22. ... Central Page 1 of 9 (page number not for citation purposes) Radiation Oncology Open Access Research Stereotactic, single-dose irradiation of stage I non- small cell lung cancer and lung metastases Peter...

Ngày tải lên: 09/08/2014, 10:21

... as lung cancer. It is more convenient for the patients and reduces health care costs. This study reports our results on patients with medically inoperable, early stage, non- small cell lung cancer ... therapy for inoperable, early stage non- small cell lung cancer Sergio L Faria* 1 , Luis Souhami 1 , Lorraine Portelance 1 , Marie Duclos 1 , Te Vuong 1 , David Small 2 and Carolyn R Freeman 1 Address: ... patients (94 %) were N0 by CT scan. Only two patients (6%) were considered to have N1 disease close to the primary lung tumor. In 19 cases ( 59% ) the tumor was in the right lung. In 22 cases ( 69% ) the...

Ngày tải lên: 09/08/2014, 10:21

... mito- mycin, vindesine, and cisplatin in unresectable stage III non- small- cell lung cancer. J Clin Oncol 199 9, 17:2 692 -2 699 . 19. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi ... chemoradiotherapy in non- small cell lung cancer (Review). In The Cochrane Library Vol- ume 1. Wiley; 2005:1-37. 25. Vokes EE: Optimal therapy for unresectable stage III non- small- cell lung cancer. J Clin ... stage I Nonsmall cell lung carcinoma. Cancer 2004, 101:1623-1631. 54. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Leb- esque J: Acute esophageal toxicity in non- small cell lung can- cer...

Ngày tải lên: 09/08/2014, 10:21

Ngày tải lên: 10/08/2014, 09:22

Ngày tải lên: 10/08/2014, 09:22

Ngày tải lên: 10/08/2014, 10:20

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 10/08/2014, 10:21